Related Experiment Videos
Uric acid as a cardiovascular risk factor in arterial hypertension
Insights
Elevated serum urate in hypertension may indicate underlying vascular damage. Further research is needed to confirm if hyperuricemia is a direct cardiovascular risk factor and guide treatment strategies.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Metabolic Disorders
Background:
- Increased serum urate is common in hypertension, but its role as an independent cardiovascular risk factor is debated.
- Hyperuricemia is linked to obesity, renal disease, hyperlipidemia, and atherosclerosis, complicating its direct association with cardiovascular risk.
Discussion:
- Arguments suggest elevated serum urate in hypertensive patients reflects renal vascular involvement.
- Reduced uric acid excretion in hypertension, potentially linked to insulin resistance and hyperinsulinism, promotes urate reabsorption.
- Tissue hypoxia from hypertensive vascular damage can increase uric acid production via adenine nucleotide degradation.
Key Insights:
- Hyperuricemia may serve as an indicator of hypertensive vascular damage.
- Uric acid overproduction is associated with increased reactive oxygen species, contributing to tissue damage.
- Understanding the link between uric acid and hypertension could inform therapeutic strategies.
Outlook:
- Further investigation is required to unequivocally demonstrate hyperuricemia as an indicator of hypertensive vascular damage.
- Establishing this link could lead to evidence-based therapeutic strategies for patients with both hypertension and hyperuricemia.
- Clarifying the role of uric acid in cardiovascular risk is crucial for patient management.
Background:
Increased serum urate concentrations is a frequent finding in patients with hypertension. Since hyperuricaemia is associated with obesity, renal disease, hyperlipidaemia, and atherosclerosis the question as to whether serum urate is a cardiovascular risk factor per se has remained elusive. In considering the relationship between uric acid and hypertension three aspects should be answered: (a) the significance of hyperuricaemia; (b) the pathophysiological mechanism of the association; and (c) whether hyperuricaemia is deleterious.
Significance Of Hyperuricaemia:
Several arguments favour the concept that increased serum urate in hypertensive patients most likely reflects renal vascular involvement.
Pathophysiological Mechanism:
Hyperuricaemia is accompanied by a relatively diminished uric acid excretion rate in hypertensive patients. Selective insulin resistance and hyperinsulinism estimulates the tubular sodium-hydrogen exchanger and facilitates the active reabsorption of urate. IS HYPERURICAEMIA DELETERIOUS?: In addition to the renal (urolithiasis) and articular disturbances that hyperuricaemia may cause, vascular damage due to arterial hypertension may limit the availability of oxygen for ATP synthesis. Tissue hypoxia determines increased adenine nucleotide degradation which ends in uric acid overproduction. The formation of uric acid is accompanied by an enhanced synthesis of reactive oxygen species which play a significant role in tissue damage. The hypothesis that hyperuricaemia indicates hypertensive vascular damage is plausible and if unequivocally demonstrated may contribute to delineate evidence-based therapeutic strategies for hypertensive-hyperuricaemic patients.